BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 26564071)

  • 1. Neurofibromatosis type 1.
    Anderson JL; Gutmann DH
    Handb Clin Neurol; 2015; 132():75-86. PubMed ID: 26564071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Café-au-lait Macules and Neurofibromatosis Type 1: A Review of the Literature.
    Bernier A; Larbrisseau A; Perreault S
    Pediatr Neurol; 2016 Jul; 60():24-29.e1. PubMed ID: 27212418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a multidisciplinary clinic of neurofibromatosis type 1 and other neurocutaneous disorders in Greece. A 3-year experience.
    Kokkinou E; Roka K; Alexopoulos A; Tsina E; Nikas I; Krallis P; Thanopoulou I; Nasi L; Makrygianni E; Tsoutsou E; Kosma K; Tsipi M; Tzetis M; Frysira H; Kattamis A; Pons R
    Postgrad Med; 2019 Sep; 131(7):445-452. PubMed ID: 31443616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurofibromatosis type 1 or Von Recklinghausen's disease].
    Pinson S; Wolkenstein P
    Rev Med Interne; 2005 Mar; 26(3):196-215. PubMed ID: 15777582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Update on Neurofibromatosis Type 1: Not Just Café-au-Lait Spots and Freckling. Part II. Other Skin Manifestations Characteristic of NF1. NF1 and Cancer.
    Hernández-Martín A; Duat-Rodríguez A
    Actas Dermosifiliogr; 2016; 107(6):465-73. PubMed ID: 26956402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofibromatosis from Head to Toe: What the Radiologist Needs to Know.
    Wang MX; Dillman JR; Guccione J; Habiba A; Maher M; Kamel S; Panse PM; Jensen CT; Elsayes KM
    Radiographics; 2022; 42(4):1123-1144. PubMed ID: 35749292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical hematologic and renal manifestations in neurofibromatosis type I: coincidence or pathophysiological link?
    Van-Gils J; Harambat J; Jubert C; Vidaud D; Llanas B; Perel Y; Lacombe D; Goizet C
    Eur J Med Genet; 2014; 57(11-12):639-42. PubMed ID: 25234363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gliomas in patients with neurofibromatosis type 1.
    Albers AC; Gutmann DH
    Expert Rev Neurother; 2009 Apr; 9(4):535-9. PubMed ID: 19344304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofibromatosis type 1.
    Gutmann DH; Ferner RE; Listernick RH; Korf BR; Wolters PL; Johnson KJ
    Nat Rev Dis Primers; 2017 Feb; 3():17004. PubMed ID: 28230061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ossifying Fibroma of Maxilla in a Female Affected by Neurofibromatosis Type 1.
    Jendi SK; Khatib S; Mistry J; Wagh A; Vaidya K; Kokane G
    Indian J Otolaryngol Head Neck Surg; 2019 Nov; 71(Suppl 3):2087-2090. PubMed ID: 31763299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Neurofibromatoses. Part 1: NF1.
    Lu-Emerson C; Plotkin SR
    Rev Neurol Dis; 2009; 6(2):E47-53. PubMed ID: 19587630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lisch nodule in neurofibromatosis type 1].
    Abaloun Y; Ajhoun Y
    Pan Afr Med J; 2017; 27():218. PubMed ID: 28979620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neurofibromatosis type 1 (von Recklinghausen's disease or peripheral neurofibromatosis): from phenotype to gene].
    Sabol Z; Kipke-Sabol L
    Lijec Vjesn; 2005; 127(11-12):303-11. PubMed ID: 16583938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofibromatosis 1 in childhood.
    North KN
    Semin Pediatr Neurol; 1998 Dec; 5(4):231-42. PubMed ID: 9874851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Developmental manifestation in children with neurofibromatosis type 1].
    Cohen R; Shuper A
    Harefuah; 2010 Jan; 149(1):49-52, 61. PubMed ID: 20422842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and genetic aspects of neurofibromatosis 1.
    Jett K; Friedman JM
    Genet Med; 2010 Jan; 12(1):1-11. PubMed ID: 20027112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pigment cell-related manifestations in neurofibromatosis type 1: an overview.
    De Schepper S; Boucneau J; Lambert J; Messiaen L; Naeyaert JM
    Pigment Cell Res; 2005 Feb; 18(1):13-24. PubMed ID: 15649148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neurofibromatosis type 1 - description of clinical features and molecular mechanism of the disease].
    Bikowska-Opalach B; Jackowska T
    Med Wieku Rozwoj; 2013; 17(4):334-40. PubMed ID: 24519776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anxiety disorders in type 1 neurofibromatosis: A case report].
    Fekih-Romdhane F; Othman S; Sahnoun C; Helayem S; Abbes Z; Bouden A
    Arch Pediatr; 2015 Sep; 22(9):956-60. PubMed ID: 26228808
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.